Your session is about to expire
← Back to Search
Preoperative Embolization for Head and Neck Cancers
Study Summary
This trial will test whether embolization done prior to surgery will improve surgical outcomes in head and neck tumors with large amounts of blood vessels.
- Head and Neck Cancer
- Head and Neck Cancers
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are allergic to ethiodized oil, poppy seeds, or poppy seed oil.You are expected to live for at least 3 more months.You have a thyroid condition that may be affected by products containing iodine.You have a tumor in your head or neck that has spread to other parts of your body.You have recently experienced a significant bleeding or injury.You are allergic to the dye used for medical imaging tests.The blood supply to your brain comes from certain arteries in your neck.People at any stage of their illness can participate.You have a tumor in your head or neck that is larger than 1 cm in size.You have a health condition that is not under control or you have another illness that could affect your ability to participate in the study.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: Treatment (PVA, EOV, tumor vessel embolization)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
What are the requirements to take part in this research experiment?
"This clinical trial seeks 20 participants with malignant neoplasms aged between 18 and 80. To be eligible, they must have a blood supply from the external carotid artery, intend to undertake surgical resection of their tumors, meet imaging requirements through MRI or CT scans, may have prior therapies under their belt; adults within the specified age range are also required with a minimum life expectancy period of 3 months. Moreover, applicants need an eGFR above 30 mL/min/1.73 m^2 not being pregnant at angiographic intervention and having extra-axial head & neck tumours greater than 2 cm in size."
Does this medical trial admit seniors over the age of 65?
"This trial only allows people aged 18 to 80, with 315 studies catering towards minors and 2,553 targeting patients over the age of 65."
What is the maximum capacity of participants enrolled in this research?
"Affirmative. The information listed on clinicaltrials.gov discloses that this research is actively searching for participants who meet the eligibility criteria. This trial was initially posted in December 1, 2022 and recently updated in November 4, 2022; a total of 20 patients are needed from one medical center to participate."
Is this clinical trial open to new participants at the moment?
"Affirmative. Clinicaltrials.gov's records demonstrate that this clinical trial, which was initially made available on December 1st 2022, is currently recruiting participants. The study requires 20 patients to be recruited from only one medical centre."
Has Angiogram been endorsed by the FDA?
"This experimental drug has been assigned a rating of 1, as there is only limited evidence regarding its safety and effectiveness."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger